Among non-small cell lung cancers (NSCLC), 90% of adenocarcinomas, 40% of squamous cell carcinomas, and 60% of large cell carcinomas are characterized by increased activity of PI3K/Akt/mTOR axis [99]. This evidence concerns the gene PIK3CA and squamous cell carcinoma.